A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies

Huge efforts have been devoted to develop therapeutic monoclonal antibodies targeting human Programmed death-ligand 1 (hPD-L1) for treating various types of human cancers. However, thus far there is no suitable animal model for evaluating the anti-tumor efficacy of such antibodies against hPD-L1. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Anfei, Peng, Di, Guo, Huanhuan, Ben, Yinyin, Zuo, Xiangyang, Wu, Fei, Yang, Xiaoli, Teng, Fei, Li, Zhen, Qian, Xueming, Qin, F. Xiao-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311961/
https://www.ncbi.nlm.nih.gov/pubmed/28202921
http://dx.doi.org/10.1038/srep42687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5311961/
https://www.ncbi.nlm.nih.gov/pubmed/28202921
http://dx.doi.org/10.1038/srep42687

Ejemplares similares